SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-074071
Filing Date
2023-03-17
Accepted
2023-03-17 17:14:01
Documents
13
Period of Report
2023-03-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d493524d8k.htm   iXBRL 8-K 28569
2 EX-1.1 d493524dex11.htm EX-1.1 19120
  Complete submission text file 0001193125-23-074071.txt   176894

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ubx-20230317.xsd EX-101.SCH 2868
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ubx-20230317_lab.xml EX-101.LAB 17978
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ubx-20230317_pre.xml EX-101.PRE 11271
7 EXTRACTED XBRL INSTANCE DOCUMENT d493524d8k_htm.xml XML 3357
Mailing Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 285 EAST GRAND AVENUE SOUTH SAN FRANCISCO CA 94080 (650) 416-1192
Unity Biotechnology, Inc. (Filer) CIK: 0001463361 (see all company filings)

IRS No.: 264726035 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38470 | Film No.: 23743776
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences